Stanic Hana Safic, Galic Zrinka Kruhonja, Dogic Vesna, Bingulac-Popovic Jasna, Jukic Irena
Department of Immunohematology, Croatian Institute of Transfusion Medicine, Zagreb, Croatia.
Department of Molecular Diagnostics, Croatian Institute of Transfusion Medicine, Zagreb, Croatia.
Transfus Med. 2023 Apr;33(2):132-136. doi: 10.1111/tme.12944. Epub 2022 Dec 1.
Existence of hundreds of RHD gene variants contributes to variable D antigen expression and inconsistencies in reporting the RHD results. The aim of the study was to determine the serological and molecular characteristics of the most prevalent RHD alleles encoding serologically weak D variants.
Blood donors (n = 145 924) were typed for D antigen using the direct serologic micromethod. Nonreactive samples were analysed in IAT method with the IgM/IgG anti-D monoclonal blend, and 0,2% (n = 263) confirmed weak D antigen expression. After genomic DNA extraction (Qiaqen, Germany), RHD genotyping was performed using in house reagents and PCR-SSP kits (Inno-Train, Germany).
The prevalence of serologically weak D in blood donor population was 0.2% (n = 263). RHD genotyping confirmed weak D allele in 92.4% and partial D allele in 7.6%. The most common was weak D type 1 (49.7%) followed by weak D type 3 (24.7%) and type 2 (9.5%). Relatively high frequency was detected for weak D type 14 (4.6%) and type 64 (2.3%). In the category of partial D phenotypes, only DVI variant was found. Direct typing has shown great variability in the strength of reactions with different clones of anti-D reagents.
Weak D type 1 is the most common weak D variant in Croatian blood donor population. The frequency of D variants and distribution of Rh phenotypes in our study was in concordance with other studies. It has been shown that serological methods and the combination of clones used, cannot distinguish variant D types, which justifies the use of molecular methods.
数百种RHD基因变体的存在导致D抗原表达的变化以及RHD结果报告的不一致。本研究的目的是确定编码血清学弱D变体的最常见RHD等位基因的血清学和分子特征。
使用直接血清学微量法对145924名献血者进行D抗原分型。对无反应性样本采用IgM/IgG抗-D单克隆混合物通过间接抗球蛋白试验(IAT)方法进行分析,263例(0.2%)样本确认有弱D抗原表达。提取基因组DNA(德国Qiagen公司产品)后,使用内部试剂和PCR-SSP试剂盒(德国Inno-Train公司)进行RHD基因分型。
献血人群中血清学弱D的发生率为0.2%(n = 263)。RHD基因分型确认92.4%为弱D等位基因,7.6%为部分D等位基因。最常见的是弱D1型(49.7%),其次是弱D3型(24.7%)和弱D2型(9.5%)。弱D14型(4.6%)和弱D64型(2.3%)的频率相对较高。在部分D表型类别中,仅发现了DVI变体。直接分型显示与不同抗-D试剂克隆的反应强度存在很大差异。
弱D1型是克罗地亚献血人群中最常见的弱D变体。我们研究中D变体的频率和Rh表型的分布与其他研究一致。已经表明血清学方法以及所使用克隆的组合无法区分变体D类型,这证明了使用分子方法的合理性。